Niagara Gazette5h
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
While there are other ways to guard against infection, like condoms, daily pills, vaginal rings and bi-monthly shots, experts ...
Unlocking the Power of Community Advocacy to Help End the HIV Epidemic in Latine Communities
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
With Threats on The Horizon, World AIDS Day Is Still a Call to Action
I'm sometimes asked how I started in AIDS organizing. Although it’s hard to pin when it happened, I will always remember ...
Pharmaceutical Technology16h
PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amass
The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...
Five things you should know about the HIV epidemic
Aids was first identified 40 years ago: these are the game changers that have revolutionised treatment – and the obstacles ...
devdiscourse17h
Breakthrough HIV Prevention Shot Faces Global Access Challenges
The twice-yearly HIV prevention shot from Gilead Sciences has proven 100% effective in women and nearly as effective in men, ...
Carlyle-backed life sciences investor launches $1.5bn clinical trials fund
In February, it announced a collaboration with California’s Gilead Sciences to develop the cancer drug Trodelvy in a deal worth up to $210mn. Trodelvy is already approved to treat some cancers ...